Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001104659-21-140386
Filing Date
2021-11-17
Accepted
2021-11-17 10:06:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B tm2133159d1_8a12b.htm 8-A12B 16047
  Complete submission text file 0001104659-21-140386.txt   17093
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-39202 | Film No.: 211418843
SIC: 2834 Pharmaceutical Preparations